Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon Aug 24, 2021 9:53am
133 Views
Post# 33754166

RE:RE:RE:CEO's latest buy

RE:RE:RE:CEO's latest buyThis scenario now places additional pressure on Tripp to possibly buy more given that he will have seen the 300 blogs here and on CEO.ca speculating on his confidence in this stock - he might be wise to pony up some more for investor purposes as he has opened the gate.

The scourge of mindless bashers is becoming tiresome here - these low lifes have one goal only and that is to tank this stock to the lowest levels possible so they can accumulate - to believe otherwise would be foolish as their only objective here is $$$ in their own pockets - not the stated well being of we stockholders they are trying to save!

Common sense dictates that the AVRT/Aristotle program will generate revenue once the amalgamation is complete - this is after all a post covid health conscious environment and we will be well established as a viable cancer detection/treatment option.

The one thing I don't want to see is another 2 to 1 or other split down the road for NAS or any other purpose - we have seen enough dillution as more will bury us.

One day when this starts its trend north, the  comedy crew here will disappear completely as they too will be happy with the cheap shares they accumulated.



Quote=davewho]possible it was just a TFSA top up. No other person in management shows any buying so far that I can see. Our new CFO starts in a couple days so will have to watch if he buys any on the open market or just sits on his options.[/quote]

<< Previous
Bullboard Posts
Next >>